ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.

Rahul Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.